Vanguard Group’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$66.7M Buy
13,227,066
+419,558
+3% +$2.11M ﹤0.01% 2002
2025
Q1
$83M Sell
12,807,508
-323,127
-2% -$2.09M ﹤0.01% 1872
2024
Q4
$96.4M Sell
13,130,635
-5,321
-0% -$39.1K ﹤0.01% 1890
2024
Q3
$98.4M Buy
13,135,956
+286,739
+2% +$2.15M ﹤0.01% 1879
2024
Q2
$114M Buy
12,849,217
+473,862
+4% +$4.22M ﹤0.01% 1770
2024
Q1
$125M Buy
12,375,355
+78,216
+0.6% +$792K ﹤0.01% 1747
2023
Q4
$124M Buy
12,297,139
+1,096,473
+10% +$11M ﹤0.01% 1747
2023
Q3
$105M Buy
11,200,666
+960,302
+9% +$9M ﹤0.01% 1786
2023
Q2
$251M Sell
10,240,364
-27,098
-0.3% -$665K 0.01% 1342
2023
Q1
$239M Buy
10,267,462
+172,961
+2% +$4.02M 0.01% 1356
2022
Q4
$255M Buy
10,094,501
+166,085
+2% +$4.2M 0.01% 1297
2022
Q3
$191M Buy
9,928,416
+1,731,172
+21% +$33.4M 0.01% 1412
2022
Q2
$209M Buy
8,197,244
+438,847
+6% +$11.2M 0.01% 1398
2022
Q1
$200M Buy
7,758,397
+428,266
+6% +$11M ﹤0.01% 1562
2021
Q4
$307M Buy
7,330,131
+109,814
+2% +$4.6M 0.01% 1336
2021
Q3
$314M Buy
7,220,317
+958,060
+15% +$41.7M 0.01% 1293
2021
Q2
$296M Buy
6,262,257
+324,143
+5% +$15.3M 0.01% 1358
2021
Q1
$304M Buy
5,938,114
+67,996
+1% +$3.49M 0.01% 1295
2020
Q4
$157M Buy
5,870,118
+336,439
+6% +$9.01M ﹤0.01% 1604
2020
Q3
$190M Buy
5,533,679
+5,173,792
+1,438% +$178M 0.01% 1316
2020
Q2
$14.7M Buy
359,887
+182,567
+103% +$7.48M ﹤0.01% 2570
2020
Q1
$6.08M Buy
177,320
+7,451
+4% +$255K ﹤0.01% 2873
2019
Q4
$2.14M Buy
+169,869
New +$2.14M ﹤0.01% 3432